RCB18350 is an antituberculosis agent and an isoxazole derivative. It demonstrates bacteriostatic properties by inhibiting the growth of Mycobacterium tuberculosis, with a minimum inhibitory concentration (MIC) of 1.25 µg/mL. RCB18350 is effective against multi-drug resistant Mycobacterium tuberculosis (MDR-TB) clinical isolates, Mycobacterium bovis BCG, and Mycobacterium avium, all of which are slow-growing mycobacteria.
Molecular Weight:
441.424
CAS Number:
[3052630-27-7]
Formula:
C19H18F3N3O4S
Target:
Antibacterial
T206702
* VAT and and shipping costs not included. Errors and price changes excepted